Today (20 July), Dr. Sophon Iamsirithavorn Deputy Director-General of the Department of Disease Control said that the results of the study on the effectiveness of the vaccine once morest COVID-19 in Chiang Mai by a research team from the Faculty of Public Health Chiang Mai University led by Prof. Dr. Suwat Jariyalertsak together with the Chiang Mai Provincial Public Health Office Continuously conducted since January 2022, AstraZeneca, Pfizer or Moderna vaccination is the fourth dose, most of which are cross-formed. Heterologous Booster Vaccination was effective in preventing infection from omicron strains up to 73%, 71% and 71%, respectively, with this level of efficacy being increased by more than 2 times compared to those treated with heterologous booster vaccination. Get only 3 doses of vaccination
The research results show that The 4th needle of the COVID-19 booster vaccination, whether it is an mRNA or virus-led vaccine. They are equally effective in preventing Omicron strains of COVID-19. In the population aged 18 years and over, immunization with booster vaccination is especially important for at-risk populations. especially the 608 group
In addition, the analysis of the data revealed that Three doses of vaccination provide protection once morest severe symptoms and death from omikron strains by up to 96% in the age group 18-59 and 97% in the age group 60 and over. 60 years and over and 7 risk groups including pregnant women Therefore, it is an important goal for vaccination with as many booster needles as possible. not less than 60% to ensure safety Reduce the risk of serious illness and death. We invite children to bring regarding 2 million elderly people who have not been vaccinated, as well as those who have received 2 doses of vaccines for more than 4 months but have not been vaccinated. The third dose, get the booster vaccination as soon as possible, as these two groups still account for more than half of the coronavirus deaths today.